Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 4:01 pm Unchanged |
2025-04-15 | 13D | Allakos Inc. ALLK |
TANG CAPITAL MANAGEMENT LLC | 8,693,687 9.600% |
0 (Unchanged) |
Filing History |
| 2025-04-04 6:57 pm Purchase |
2025-03-28 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
TANG CAPITAL MANAGEMENT LLC | 2,178,609 5.200% |
2,178,609 (New Position) |
Filing History |
| 2025-04-03 4:40 pm Purchase |
2025-04-01 | 13D | Allakos Inc. ALLK |
TANG CAPITAL MANAGEMENT LLC | 8,693,687 9.600% |
247 (+0.00%) |
Filing History |
| 2025-03-12 5:58 pm Purchase |
2025-03-10 | 13D | Acelyrin, Inc. SLRN |
TANG CAPITAL MANAGEMENT LLC | 8,824,693 8.800% |
1,526,365 (+20.91%) |
Filing History |
| 2025-03-10 5:24 pm Purchase |
2025-03-03 | 13D | Pliant Therapeutics, Inc. PLRX |
TANG CAPITAL MANAGEMENT LLC | 5,859,044 9.600% |
5,859,044 (New Position) |
Filing History |
| 2025-03-04 5:04 pm Purchase |
2025-02-28 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
TANG CAPITAL MANAGEMENT LLC | 10,029,500 7.300% |
2,800,000 (+38.73%) |
Filing History |
| 2025-02-27 7:02 pm Purchase |
2025-02-25 | 13D | Acelyrin, Inc. SLRN |
TANG CAPITAL MANAGEMENT LLC | 7,298,328 7.300% |
2,000,000 (+37.75%) |
Filing History |
| 2025-02-21 5:05 pm Purchase |
2025-02-13 | 13D | CARGO Therapeutics, Inc. Common Stock CRGX |
TANG CAPITAL MANAGEMENT LLC | 2,729,288 5.900% |
2,729,288 (New Position) |
Filing History |
| 2025-02-20 4:15 pm Purchase |
2025-02-18 | 13D | Acelyrin, Inc. SLRN |
TANG CAPITAL MANAGEMENT LLC | 5,298,328 5.300% |
5,298,328 (New Position) |
Filing History |
| 2025-02-14 8:00 pm Purchase |
2025-02-07 | 13D | Galapagos NV GLPG |
TANG CAPITAL MANAGEMENT LLC | 4,910,525 7.500% |
4,910,525 (New Position) |
Filing History |
| 2025-02-14 4:00 pm Sale |
2024-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
TANG CAPITAL MANAGEMENT LLC | 221,716 0.600% |
-2,186,084 (-90.79%) |
Filing History |
| 2025-02-14 4:00 pm Sale |
2024-12-31 | 13G | Monopar Therapeutics Inc. MNPR |
TANG CAPITAL MANAGEMENT LLC | 0 0.000% |
-200,000 (Position Closed) |
Filing History |
| 2025-02-14 4:00 pm Purchase |
2024-12-31 | 13G | Cybin Inc. CYBN |
TANG CAPITAL MANAGEMENT LLC | 1,330,097 6.700% |
224,664 (+20.32%) |
Filing History |
| 2025-02-03 6:34 pm Purchase |
2025-01-27 | 13D | Allakos Inc. ALLK |
TANG CAPITAL MANAGEMENT LLC | 8,693,440 9.700% |
8,693,440 (New Position) |
Filing History |
| 2025-01-27 6:20 pm Purchase |
2025-01-17 | 13G | Nkarta, Inc. NKTX |
TANG CAPITAL MANAGEMENT LLC | 7,014,100 9.900% |
7,014,100 (New Position) |
Filing History |
| 2025-01-16 5:17 pm Purchase |
2025-01-08 | 13G | Compass Therapeutics, Inc. CMPX |
TANG CAPITAL MANAGEMENT LLC | 7,400,000 5.400% |
7,400,000 (New Position) |
Filing History |
| 2024-12-03 5:23 pm Purchase |
2024-11-25 | 13G | Cybin Inc. CYBN |
TANG CAPITAL MANAGEMENT LLC | 1,105,433 5.500% |
1,105,433 (New Position) |
Filing History |
| 2024-11-29 2:00 pm Purchase |
2024-11-21 | 13G | Journey Medical Corporation DERM |
TANG CAPITAL MANAGEMENT LLC | 1,523,938 7.300% |
1,523,938 (New Position) |
Filing History |
| 2024-11-14 4:26 pm Purchase |
2024-11-08 | 13G | LianBio LIANY |
TANG CAPITAL MANAGEMENT LLC | 8,051,815 7.500% |
8,051,815 (New Position) |
Filing History |
| 2024-11-14 4:00 pm Purchase |
2024-09-30 | 13G | CytomX Therapeutics, Inc. CTMX |
TANG CAPITAL MANAGEMENT LLC | 7,811,760 9.990% |
7,811,760 (New Position) |
Filing History |